GLP-1 Agonists Showed Dose-Specific ON-Medication Motor Effects in Parkinson’s Disease
TL;DR: A 2026 systematic review and exploratory network meta-analysis of 5 randomized trials in Neurological Sciences found dose-specific ON-medication motor improvements, measured while usual Parkinson’s drugs were active, for some GLP-1 receptor agonists, gl…
Read article